{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T10:58:31Z","timestamp":1787914711832,"version":"build-2784847793"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Nature Fund Program","award":["82074373"],"award-info":[{"award-number":["82074373"]}]},{"name":"Anhui University Collaborative Innovation Project","award":["GXXT-2020-025"],"award-info":[{"award-number":["GXXT-2020-025"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00011-025-02034-3","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T08:28:15Z","timestamp":1747902495000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Crosstalk between N6-methyladenosine modification and ncRNAs in rheumatic diseases: therapeutic and diagnostic implications"],"prefix":"10.1007","volume":"74","author":[{"given":"Jianting","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanfan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,22]]},"reference":[{"issue":"1","key":"2034_CR1","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/s41392-022-01175-9","volume":"7","author":"L Cui","year":"2022","unstructured":"Cui L, Ma R, Cai J, et al. RNA modifications: importance in immune cell biology and related diseases. Signal Transduct Target. 2022;7(1):334.","journal-title":"Signal Transduct Target"},{"issue":"Pt 2","key":"2034_CR2","volume":"253","author":"Y Chen","year":"2023","unstructured":"Chen Y, Jiang Z, Yang Y, et al. The functions and mechanisms of post-translational modification in protein regulators of RNA methylation: current status and future perspectives. Int J Biol Macromol. 2023;253(Pt 2): 126773.","journal-title":"Int J Biol Macromol"},{"issue":"8","key":"2034_CR3","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41571-023-00774-x","volume":"20","author":"X Deng","year":"2023","unstructured":"Deng X, Qing Y, Horne D, et al. The roles and implications of RNA mA modification in cancer. Nat Rev Clin Oncol. 2023;20(8):507\u201326.","journal-title":"Nat Rev Clin Oncol"},{"key":"2034_CR4","volume":"13","author":"L Li","year":"2022","unstructured":"Li L, Xu N, Liu J, et al. m6A methylation in cardiovascular diseases: from mechanisms to therapeutic potential. Front Genet. 2022;13: 908976.","journal-title":"Front Genet"},{"key":"2034_CR5","volume":"13","author":"L Jiang","year":"2022","unstructured":"Jiang L, Li X, Wang S, et al. The role and regulatory mechanism of mA methylation in the nervous system. Front Genet. 2022;13: 962774.","journal-title":"Front Genet"},{"issue":"1","key":"2034_CR6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s13075-023-03149-w","volume":"25","author":"Y Huang","year":"2023","unstructured":"Huang Y, Xue Q, Chang J, et al. M6A methylation modification in autoimmune diseases, a promising treatment strategy based on epigenetics. Arthritis Res Ther. 2023;25(1):189.","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"2034_CR7","doi-asserted-by":"crossref","first-page":"128","DOI":"10.2174\/1574892812666170105113415","volume":"12","author":"FE Nicolas","year":"2017","unstructured":"Nicolas FE. Role of ncRNAs in development, diagnosis and treatment of human cancer. Recent Pat Anticancer Drug Discov. 2017;12(2):128\u201335.","journal-title":"Recent Pat Anticancer Drug Discov"},{"issue":"3","key":"2034_CR8","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/BOR.0000000000000594","volume":"31","author":"E Liu","year":"2019","unstructured":"Liu E, Perl A. Pathogenesis and treatment of autoimmune rheumatic diseases. Curr Opin Rheumatol. 2019;31(3):307\u201315.","journal-title":"Curr Opin Rheumatol"},{"issue":"2","key":"2034_CR9","volume":"10","author":"M Yang","year":"2024","unstructured":"Yang M, Hu X, Tang B, et al. Exploring the interplay between methylation patterns and non-coding RNAs in non-small cell lung cancer: Implications for pathogenesis and therapeutic targets. Heliyon. 2024;10(2): e24811.","journal-title":"Heliyon"},{"key":"2034_CR10","volume":"12","author":"L Tang","year":"2021","unstructured":"Tang L, Wei X, Li T, et al. NEmerging perspectives of RNA-methyladenosine (mA) modification on immunity and autoimmune diseases. Front Immunol. 2021;12: 630358.","journal-title":"Front Immunol"},{"issue":"1","key":"2034_CR11","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.gendis.2023.02.013","volume":"11","author":"Y Shan","year":"2024","unstructured":"Shan Y, Chen W, Li Y, et al. The role of mA RNA methylation in autoimmune diseases: novel therapeutic opportunities. Genes Dis. 2024;11(1):252\u201367.","journal-title":"Genes Dis"},{"issue":"4","key":"2034_CR12","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.molcel.2019.04.025","volume":"74","author":"H Shi","year":"2019","unstructured":"Shi H, Wei J, He C. Where, when, and how: context-dependent functions of RNA methylation writers, readers, and erasers. Mol Cell. 2019;74(4):640\u201350.","journal-title":"Mol Cell"},{"issue":"9","key":"2034_CR13","volume":"10","author":"WX Ru","year":"2020","unstructured":"Ru WX, Zhang XY, Yue BL, et al. Insight into m(6)A methylation from occurrence to functions. Open Biol. 2020;10(9): 200091.","journal-title":"Open Biol"},{"issue":"2","key":"2034_CR14","volume":"297","author":"W Zhang","year":"2021","unstructured":"Zhang W, Qian Y, Jia GF. The detection and functions of RNA modification m(6)A based on m(6)A writers and erasers. J Biol Chem. 2021;297(2): 100973.","journal-title":"J Biol Chem"},{"issue":"5","key":"2034_CR15","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1261\/rna.079988.124","volume":"30","author":"Z Sara","year":"2024","unstructured":"Sara Z, Jaffrey SR. Understanding the redundant functions of the m(6)A-binding YTHDF proteins. RNA. 2024;30(5):468\u201381.","journal-title":"RNA"},{"key":"2034_CR16","volume":"173","author":"YW Peng","year":"2024","unstructured":"Peng YW, Zhang M, Hu JK. Non-coding RNAs involved in fibroblast-like synoviocyte functioning in arthritis rheumatoid: from pathogenesis to therapy. Cytokine. 2024;173: 156418.","journal-title":"Cytokine"},{"issue":"6","key":"2034_CR17","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.tcb.2011.04.001","volume":"21","author":"O Wapinski","year":"2011","unstructured":"Wapinski O, Chang HY. Long noncoding RNAs and human disease. Trends Cell Biol. 2011;21(6):354\u201361.","journal-title":"Trends Cell Biol"},{"key":"2034_CR18","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.cell.2018.01.011","volume":"172","author":"F Kopp","year":"2018","unstructured":"Kopp F, Mendell JT. Functional classification and experimental dissection of long noncoding RNAs. Cell. 2018;172:393\u2013407.","journal-title":"Cell"},{"key":"2034_CR19","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12943-020-01286-3","volume":"19","author":"WY Zhou","year":"2020","unstructured":"Zhou WY, Cai ZR, Liu J, et al. Circular Rna: metabolism, functions and interactions with proteins. Mol Cancer. 2020;19:172.","journal-title":"Mol Cancer"},{"issue":"3","key":"2034_CR20","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/jpp\/rgac096","volume":"75","author":"YR Huang","year":"2023","unstructured":"Huang YR, Xue QY, Cheng CL, et al. Circular RNA in autoimmune diseases: special emphasis on regulation mechanism in RA and SLE. J Pharm Pharmacol. 2023;75(3):370\u201384.","journal-title":"J Pharm Pharmacol"},{"key":"2034_CR21","volume":"134","author":"HM Li","year":"2024","unstructured":"Li HM, Wang LJ, Wang YP, et al. Differences in the expression of long noncoding RNAs in peripheral blood mononuclear cells indicate potential biomarkers for rheumatoid arthritis. Int Immunopharmacol. 2024;134: 112218.","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"2034_CR22","first-page":"66","volume":"12","author":"LH Qiao","year":"2023","unstructured":"Qiao LH, Gu J, Ni YJ, et al. RNA-Seq reveals the mRNAs, miRNAs, and lncRNAs expression profile of knee joint synovial tissue in osteoarthritis patients. J Clin Med. 2023;12(4):66.","journal-title":"J Clin Med"},{"issue":"1","key":"2034_CR23","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1186\/s12891-024-07396-z","volume":"25","author":"JQ Kou","year":"2024","unstructured":"Kou JQ, Bie YC, Liu MQ, et al. Identification and bioinformatics analysis of lncRNAs in serum of patients with ankylosing spondylitis. BMC Musculoskelet Disord. 2024;25(1):291.","journal-title":"BMC Musculoskelet Disord"},{"issue":"4","key":"2034_CR24","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1177\/0961203319830493","volume":"28","author":"Q Miao","year":"2019","unstructured":"Miao Q, Zhong Z, Jiang Z, et al. RNA-seq of circular RNAs identified circPTPN22 as a potential new activity indicator in systemic lupus erythematosus. Lupus. 2019;28(4):520\u20138.","journal-title":"Lupus"},{"key":"2034_CR25","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nature12986","volume":"505","author":"Y Tay","year":"2014","unstructured":"Tay Y, Rinn J, Pandolfi PP. The multilayered complexity of ceRNA crosstalk and competition. Nature. 2014;505:344\u201352.","journal-title":"Nature"},{"issue":"1","key":"2034_CR26","doi-asserted-by":"crossref","first-page":"2189136","DOI":"10.1080\/08916934.2023.2189136","volume":"56","author":"Y Sun","year":"2023","unstructured":"Sun Y, Jiang Y, Pan LY, et al. LncRNA OIP5-AS1\/miR-410-3p\/Wnt7b axis promotes the proliferation of rheumatoid arthritis fibroblast-like synoviocytes via regulating the Wnt\/\u03b2-catenin pathway. Autoimmunity. 2023;56(1):2189136.","journal-title":"Autoimmunity"},{"key":"2034_CR27","first-page":"66","volume":"6","author":"CZ Ni","year":"2024","unstructured":"Ni CZ, Zhang WL, Qiu S, et al. Long non-coding RNA DLEU1 promotes progression of osteoarthritis via miR-492\/TLR8 axis. Curr Pharm Biotechnol. 2024;6:66.","journal-title":"Curr Pharm Biotechnol"},{"issue":"1","key":"2034_CR28","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1186\/s13018-023-04003-0","volume":"18","author":"LL Yi","year":"2023","unstructured":"Yi LL, Song CJ, Liu YY, et al. Down-regulation of long noncoding RNA HULC inhibits the inflammatory response in ankylosing spondylitis by reducing miR-556-5p-mediated YAP1 expression. J Orthop Surg Res. 2023;18(1):551.","journal-title":"J Orthop Surg Res"},{"issue":"128","key":"2034_CR29","first-page":"111539","volume":"15","author":"HJ Zou","year":"2024","unstructured":"Zou HJ, Ma S, Li L, et al. Downregulation of circular RNA ETS1 promotes SLE activity and inhibits Treg cell differentiation through miR-1205\/FoxP3 molecular axis. Int Immunopharmacol. 2024;15(128):111539.","journal-title":"Int Immunopharmacol"},{"key":"2034_CR30","volume":"9","author":"Y Wang","year":"2021","unstructured":"Wang Y, Li L, Li J, et al. The emerging role of m6A modification in regulating the immune system and autoimmune diseases. Front Cell Dev Biol. 2021;9: 755691.","journal-title":"Front Cell Dev Biol"},{"key":"2034_CR31","volume":"12","author":"S Wu","year":"2021","unstructured":"Wu S, Li XF, Wu YY, et al. N(6)-methyladenosine and rheumatoid arthritis: a comprehensive review. Front Immunol. 2021;12: 731842.","journal-title":"Front Immunol"},{"key":"2034_CR32","volume":"55","author":"J Han","year":"2022","unstructured":"Han J, Kong H, Wang X, et al. Novel insights into the interaction between N6-methyladenosine methylation and noncoding RNAs in musculoskeletal disorders. Cell Prolif. 2022;55: e13294.","journal-title":"Cell Prolif"},{"key":"2034_CR33","first-page":"365","volume":"23","author":"IB Mclnnes","year":"2011","unstructured":"Mclnnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;23:365.","journal-title":"N Engl J Med"},{"issue":"11","key":"2034_CR34","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s11547-019-01002-2","volume":"124","author":"E Filippucci","year":"2019","unstructured":"Filippucci E, Cipolletta E, Mashadi Mirza R, et al. Ultrasound imaging in rheumatoid arthritis. Radiol Med. 2019;124(11):1087\u2013100.","journal-title":"Radiol Med"},{"key":"2034_CR35","first-page":"66","volume":"14","author":"H Jiang","year":"2024","unstructured":"Jiang H, Cao K, Fan C, et al. Transcriptome-wide high-throughput m6A sequencing of differential m6A methylation patterns in the human rheumatoid arthritis fibroblast-like synoviocytes cell line MH7A. J Inflamm Res. 2024;14:66.","journal-title":"J Inflamm Res"},{"key":"2034_CR36","volume":"8","author":"D Fan","year":"2020","unstructured":"Fan D, Xia Y, Lu C, et al. Regulatory role of the RNA N(6)-methyladenosine modification in immunoregulatory cells and immune-related bone homeostasis associated with rheumatoid arthritis. Front Cell Dev Biol. 2020;8: 627893.","journal-title":"Front Cell Dev Biol"},{"key":"2034_CR37","first-page":"66","volume":"6","author":"L Wan","year":"2022","unstructured":"Wan L, Liu J, Huang C, et al. Comprehensive analysis and functional characteristics of differential expression of N6-methyladenosine methylation modification in the whole transcriptome of rheumatoid arthritis. Mediators Inflamm. 2022;6:66.","journal-title":"Mediators Inflamm"},{"key":"2034_CR38","first-page":"66","volume":"6","author":"Q Luo","year":"2020","unstructured":"Luo Q, Gao Y, Zhang L, et al. ALKBH5 decreased, and in peripheral blood are as risk factors for rheumatoid arthritis. Biomed Res Int. 2020;6:66.","journal-title":"Biomed Res Int"},{"issue":"1","key":"2034_CR39","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/1547691X.2022.2067916","volume":"19","author":"F Yao","year":"2022","unstructured":"Yao F, Xu C, Gao Y, et al. YTHDF2Expression and clinical significance of the m6A reader in peripheral blood mononuclear cells from rheumatoid arthritis patients. J Immunotoxicol. 2022;19(1):53\u201360.","journal-title":"J Immunotoxicol"},{"issue":"1","key":"2034_CR40","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13075-024-03290-0","volume":"26","author":"G Li","year":"2024","unstructured":"Li G, Fang Y, Xu N, et al. Fibroblast-like synoviocytes-derived exosomal circFTO deteriorates rheumatoid arthritis by enhancing N6-methyladenosine modification of SOX9 in chondrocytes. Arthritis Res Ther. 2024;26(1):56.","journal-title":"Arthritis Res Ther"},{"issue":"24","key":"2034_CR41","doi-asserted-by":"crossref","first-page":"10009","DOI":"10.18632\/aging.204439","volume":"14","author":"L Wan","year":"2022","unstructured":"Wan L, Liu J, Huang C, et al. Role of m6A modification and novel circ_0066715\/miR-486-5p\/ETS1 axis in rheumatoid arthritis macrophage polarization progression. Aging. 2022;14(24):10009\u201326.","journal-title":"Aging"},{"issue":"Pt A","key":"2034_CR42","volume":"124","author":"H Luo","year":"2023","unstructured":"Luo H, Wei J, Wu S, et al. Exploring CircRNA N6-methyladenosine in human rheumatoid arthritis: hyper-methylated hsa_circ_0007259 as a potential biomarker and its involvement in the hsa_circ_0007259\/hsa_miR-21-5p\/STAT3 axis. Int Immunopharmacol. 2023;124(Pt A): 110938.","journal-title":"Int Immunopharmacol"},{"issue":"23\u201324","key":"2034_CR43","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1080\/15384101.2024.2302281","volume":"22","author":"J Wen","year":"2023","unstructured":"Wen J, Liu J, Wan L, et al. mA-mediated lncRNA MAPKAPK5-AS1 induces apoptosis and suppresses inflammation via regulating miR-146a-3p\/SIRT1\/NF-\u03baB axis in rheumatoid arthritis. Cell Cycle. 2023;22(23\u201324):2602\u201321.","journal-title":"Cell Cycle"},{"key":"2034_CR44","volume":"8","author":"W Shi","year":"2021","unstructured":"Shi W, Zheng Y, Luo S, et al. METTL3 promotes activation and inflammation of FLSs through the NF-\u03baB signaling pathway in rheumatoid arthritis. Front Med. 2021;8: 607585.","journal-title":"Front Med"},{"issue":"5","key":"2034_CR45","doi-asserted-by":"crossref","first-page":"C1089","DOI":"10.1152\/ajpcell.00575.2022","volume":"324","author":"X Li","year":"2023","unstructured":"Li X, Xu X, Zhang Q, et al. METTL14 promotes fibroblast-like synoviocytes activation via the LASP1\/SRC\/AKT axis in rheumatoid arthritis. Am J Physiol Cell Physiol. 2023;324(5):C1089\u2013100.","journal-title":"Am J Physiol Cell Physiol"},{"key":"2034_CR46","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.bbrc.2023.05.087","volume":"668","author":"J Xiao","year":"2023","unstructured":"Xiao J, Cai X, Wang R, et al. ALKBH5-YTHDF2 m6A modification axis inhibits rheumatoid arthritis progression by suppressing NLRP3. Biochem Biophys Res Commun. 2023;668:70\u20136.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"2034_CR47","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41420-024-01988-3","volume":"10","author":"Y Nan","year":"2024","unstructured":"Nan Y, Chen M, Wu W, et al. IGF2BP2 regulates the inflammation of fibroblast-like synoviocytes via GSTM5 in rheumatoid arthritis. Cell Death Discov. 2024;10(1):215.","journal-title":"Cell Death Discov"},{"issue":"4","key":"2034_CR48","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2024.167112","volume":"1870","author":"T Miao","year":"2024","unstructured":"Miao T, Qiu Y, Chen J, et al. METTL3 knockdown suppresses RA-FLS activation through mA-YTHDC2-mediated regulation of AMIGO2. Biochim Biophys Acta Mol Basis Dis. 2024;1870(4): 167112.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"5","key":"2034_CR49","volume":"19","author":"Z Ban","year":"2024","unstructured":"Ban Z, Li Z, Xing S, et al. IGF2BP3 regulates the expression of RRM2 and promotes the progression of rheumatoid arthritis via RRM2\/Akt\/MMP-9 pathway. PLoS ONE. 2024;19(5): e0303593.","journal-title":"PLoS ONE"},{"issue":"1","key":"2034_CR50","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.berh.2014.01.004","volume":"28","author":"LJ Victoria","year":"2014","unstructured":"Victoria LJ, David JH. The epidemiology of osteoarthritis. Best Pract Res Clin Rheumatol. 2014;28(1):5\u201315.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"4","key":"2034_CR51","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1136\/annrheumdis-2020-218089","volume":"80","author":"WH Hu","year":"2021","unstructured":"Hu WH, Chen YQ, Dou C, et al. Microenvironment in subchondral bone: predominant regulator for the treatment of osteoarthritis. Ann Rheum Dis. 2021;80(4):413\u201322.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"2034_CR52","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.joca.2020.11.003","volume":"29","author":"A Ratneswaran","year":"2021","unstructured":"Ratneswaran A, Kapoor M. Osteoarthritis year in review: genetics, genomics, epigenetics. Osteoarthr Cartil. 2021;29(2):151\u201360.","journal-title":"Osteoarthr Cartil"},{"issue":"4","key":"2034_CR53","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1080\/00325481.2020.1730669","volume":"132","author":"F Berenbaum","year":"2020","unstructured":"Berenbaum F, Walker C. Osteoarthritis and inflammation: a serious disease with overlapping phenotypic patterns. Postgrad Med. 2020;132(4):377\u201384.","journal-title":"Postgrad Med"},{"key":"2034_CR54","volume":"9","author":"J Luo","year":"2021","unstructured":"Luo J, Xu T, Sun K. N6-methyladenosine RNA modification in inflammation: roles, mechanisms, and applications. Front Cell Dev Biol. 2021;9: 670711.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"2034_CR55","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s12276-023-01135-5","volume":"56","author":"XY An","year":"2024","unstructured":"An XY, Wang RL, Lv ZY, et al. WTAP-mediated m(6)A modification of FRZB triggers the inflammatory response via the Wnt signaling pathway in osteoarthritis. Exp Mol Med. 2024;56(1):156\u201367.","journal-title":"Exp Mol Med"},{"key":"2034_CR56","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bbrc.2022.09.103","volume":"634","author":"Yu Bx","year":"2022","unstructured":"Bx Yu, Ay Zeng, Liu HY, et al. MiR-654-3p, reduced by the excessive ALKBH5, alleviated the inflammation in OA by targeting TNFRSF9, the trigger of the NF-\u03baB pathway. Biochem Biophys Res Commun. 2022;634:30\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"2034_CR57","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.bbrc.2019.05.168","volume":"516","author":"QB Liu","year":"2019","unstructured":"Liu QB, Li M, Jiang L, et al. METTL3 promotes experimental osteoarthritis development by regulating inflammatory response and apoptosis in chondrocyte. Biochem Biophys Res Commun. 2019;516(1):22\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"2034_CR58","first-page":"66","volume":"6","author":"XC Xiong","year":"2023","unstructured":"Xiong XC, Xiong H, Peng J, et al. METTL3 regulates the m(6)A modification of NEK7 to inhibit the formation of osteoarthritis. Cartilage. 2023;6:66.","journal-title":"Cartilage"},{"key":"2034_CR59","volume":"114","author":"DF Cai","year":"2023","unstructured":"Cai DF, Zhang J, Yang J, et al. Overexpression of FTO alleviates osteoarthritis by regulating the processing of miR-515-5p and the TLR4\/MyD88\/NF-\u03baB axis. Int Immunopharmacol. 2023;114: 109524.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"2034_CR60","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s12964-023-01228-8","volume":"21","author":"ZW Lin","year":"2023","unstructured":"Lin ZW, Jiang T, Zheng W, et al. N6-methyladenosine (m6A) methyltransferase WTAP-mediated miR-92b-5p accelerates osteoarthritis progression. Cell Commun Signal. 2023;21(1):199.","journal-title":"Cell Commun Signal"},{"issue":"1","key":"2034_CR61","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1136\/annrheumdis-2021-221091","volume":"81","author":"X Chen","year":"2022","unstructured":"Chen X, Gong W, Shao XY, et al. METTL3-mediated m(6)A modification of ATG7 regulates autophagy-GATA4 axis to promote cellular senescence and osteoarthritis progression. Ann Rheum Dis. 2022;81(1):87\u201399.","journal-title":"Ann Rheum Dis"},{"key":"2034_CR62","doi-asserted-by":"crossref","first-page":"116182","DOI":"10.1016\/j.bone.2021.116182","volume":"154","author":"Y He","year":"2022","unstructured":"He Y, WangW XuXX, et al. Mettl3 inhibits the apoptosis and autophagy of chondrocytes in inflammation through mediating Bcl2 stability via Ythdf1-mediated m(6)A modification. Bone. 2022;154:116182.","journal-title":"Bone"},{"issue":"1","key":"2034_CR63","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/s41420-022-00890-0","volume":"8","author":"JD Ren","year":"2022","unstructured":"Ren JD, Li YC, Wuermanbieke S, et al. N(6)-methyladenosine (m(6)A) methyltransferase METTL3-mediated LINC00680 accelerates osteoarthritis through m(6)A\/SIRT1 manner. Cell Death Discov. 2022;8(1):240.","journal-title":"Cell Death Discov"},{"issue":"11","key":"2034_CR64","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1038\/s12276-021-00696-7","volume":"53","author":"JS Yang","year":"2021","unstructured":"Yang JS, Zhang M, Yang DW, et al. m(6)A-mediated upregulation of AC008 promotes osteoarthritis progression through the miR-328-3p-AQP1\/ANKH axis. Exp Mol Med. 2021;53(11):1723\u201334.","journal-title":"Exp Mol Med"},{"issue":"6","key":"2034_CR65","volume":"42","author":"YT Tang","year":"2023","unstructured":"Tang YT, Hong FL, Ding SY, et al. METTL3-mediated m(6)A modification of IGFBP7-OT promotes osteoarthritis progression by regulating the DNMT1\/DNMT3a-IGFBP7 axis. Cell Rep. 2023;42(6): 112589.","journal-title":"Cell Rep"},{"issue":"2","key":"2034_CR66","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.molmed.2009.12.005","volume":"16","author":"JC Crisp\u00edn","year":"2010","unstructured":"Crisp\u00edn JC, Stamatis-Nick C, Kis-Toth LK, et al. Pathogenesis of human systemic lupus erythematosus: recent advances. Trends Mol Med. 2010;16(2):47\u201357.","journal-title":"Trends Mol Med"},{"issue":"2","key":"2034_CR67","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1615\/CritRevImmunol.v25.i2.30","volume":"25","author":"G Nagy","year":"2005","unstructured":"Nagy G, Koncz A, Perl A. T- and B-cell abnormalities in systemic lupus erythematosus. Crit Rev Immunol. 2005;25(2):123\u201340.","journal-title":"Crit Rev Immunol"},{"key":"2034_CR68","volume":"12","author":"XW Zhao","year":"2021","unstructured":"Zhao XW, Ge L, Wang J, et al. Exploration of potential integrated models of N6-methyladenosine immunity in systemic lupus erythematosus by bioinformatic analyses. Front Immunol. 2021;12: 752736.","journal-title":"Front Immunol"},{"key":"2034_CR69","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.molimm.2022.01.006","volume":"143","author":"J Wu","year":"2022","unstructured":"Wu J, Deng LJ, Xia YR, et al. Involvement of N6-methyladenosine modifications of long noncoding RNAs in systemic lupus erythematosus. Mol Immunol. 2022;143:77\u201384.","journal-title":"Mol Immunol"},{"key":"2034_CR70","volume":"12","author":"L Tang","year":"2021","unstructured":"Tang L, Wei X, Li T, et al. Emerging perspectives of RNA N6-methyladenosine (m6A) modification on immunity and autoimmune diseases. Front Immunol. 2021;12: 630358.","journal-title":"Front Immunol"},{"key":"2034_CR71","volume":"9","author":"X Lv","year":"2021","unstructured":"Lv X, Liu X, Zhao M, et al. RNA methylation in systemic lupus erythematosus. Front Cell Dev Biol. 2021;9: 696559.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"2034_CR72","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s10020-023-00643-4","volume":"29","author":"X Lu","year":"2023","unstructured":"Lu X, Wei XY, Zhu H, et al. m(6)A methyltransferase METTL3 programs CD4(+) T-cell activation and effector T-cell differentiation in systemic lupus erythematosus. Mol Med. 2023;29(1):46.","journal-title":"Mol Med"},{"issue":"27","key":"2034_CR73","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.2174\/1381612828666220617154204","volume":"28","author":"LJ Deng","year":"2022","unstructured":"Deng LJ, Fang XY, Wu J, et al. ALKBH5 expression could affect the function of T cells in systemic lupus erythematosus patients: a case-control study. Curr Pharm Des. 2022;28(27):2270\u20138.","journal-title":"Curr Pharm Des"},{"key":"2034_CR74","first-page":"8193895","volume":"2020","author":"Q Luo","year":"2020","unstructured":"Luo Q, Fu BQ, Zhang L, et al. Decreased peripheral blood ALKBH5 correlates with markers of autoimmune response in systemic lupus erythematosus. Dis Markers. 2020;2020:8193895.","journal-title":"Dis Markers"},{"issue":"9","key":"2034_CR75","volume":"8","author":"Q Luo","year":"2020","unstructured":"Luo Q, Rao JY, Zhang L, et al. The study of METTL14, ALKBH5, and YTHDF2 in peripheral blood mononuclear cells from systemic lupus erythematosus. Mol Genet Genomic Med. 2020;8(9): e1298.","journal-title":"Mol Genet Genomic Med"},{"issue":"1","key":"2034_CR76","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13075-022-02732-x","volume":"24","author":"XW Zhao","year":"2022","unstructured":"Zhao XW, Dong R, Zhang LL, et al. N6-methyladenosine-dependent modification of circGARS acts as a new player that promotes SLE progression through the NF-\u03baB\/A20 axis. Arthritis Res Ther. 2022;24(1):37.","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"2034_CR77","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/rheumatology\/ket387","volume":"53","author":"LE Dean","year":"2014","unstructured":"Dean LE, Jones GT, Macdonald AG, et al. Global prevalence of ankylosing spondylitis. Rheumatology. 2014;53(4):650\u20137.","journal-title":"Rheumatology"},{"key":"2034_CR78","doi-asserted-by":"crossref","first-page":"922219","DOI":"10.3389\/fmed.2022.922219","volume":"9","author":"Q Luo","year":"2022","unstructured":"Luo Q, Guo Y, Xiao Q, et al. Expression and clinical significance of the m6A RNA-binding proteins YTHDF2 in peripheral blood mononuclear cells from new-onset ankylosing spondylitis. Front Med. 2022;9:922219.","journal-title":"Front Med"},{"key":"2034_CR79","volume":"9","author":"Q Luo","year":"2022","unstructured":"Luo Q, Guo YQ, Xiao QY, et al. Expression and clinical significance of the m6A RNA-binding proteins YTHDF2 in peripheral blood mononuclear cells from new-onset ankylosing spondylitis. Front Med. 2022;9: 922219.","journal-title":"Front Med"},{"issue":"1","key":"2034_CR80","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1038\/s41598-024-53184-z","volume":"14","author":"D Guo","year":"2024","unstructured":"Guo D, Liu JY, Li S, et al. Analysis of m6A regulators related immune characteristics in ankylosing spondylitis by integrated bioinformatics and computational strategies. Sci Rep. 2024;14(1):2724.","journal-title":"Sci Rep"},{"issue":"1","key":"2034_CR81","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1186\/s13018-023-04254-x","volume":"18","author":"ZW Luan","year":"2023","unstructured":"Luan ZW, Wang YS. Association between ankylosing spondylitis and m6A methylation. J Orthop Surg Res. 2023;18(1):757.","journal-title":"J Orthop Surg Res"},{"key":"2034_CR82","volume":"257","author":"YT Chen","year":"2023","unstructured":"Chen YT, Wu Y, Fang LL, et al. METTL14-m6A-FOXO3a axis regulates autophagy and inflammation in ankylosing spondylitis. Clin Immunol. 2023;257: 109838.","journal-title":"Clin Immunol"},{"issue":"6","key":"2034_CR83","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41419-021-03869-4","volume":"12","author":"ZF Li","year":"2021","unstructured":"Li ZF, Wang P, Li JT, et al. The N(6)-methyladenosine demethylase ALKBH5 negatively regulates the osteogenic differentiation of mesenchymal stem cells through PRMT6. Cell Death Dis. 2021;12(6):578.","journal-title":"Cell Death Dis"},{"key":"2034_CR84","doi-asserted-by":"crossref","first-page":"1371461","DOI":"10.3389\/fmed.2024.1371461","volume":"11","author":"XY Wang","year":"2024","unstructured":"Wang XY, Kong YQ, Li ZG. Advantages of Chinese herbal medicine in treating rheumatoid arthritis: a focus on its anti-inflammatory and anti-oxidative effects. Front Med. 2024;11:1371461.","journal-title":"Front Med"},{"key":"2034_CR85","volume":"301","author":"YQ Sun","year":"2023","unstructured":"Sun YQ, Liu J, Xin L, et al. Xinfeng capsule inhibits inflammation and oxidative stress in rheumatoid arthritis by up-regulating LINC00638 and activating Nrf2\/HO-1 pathway. J Ethnopharmacol. 2023;301: 115839.","journal-title":"J Ethnopharmacol"},{"key":"2034_CR86","doi-asserted-by":"crossref","first-page":"117677","DOI":"10.1016\/j.jep.2023.117677","volume":"323","author":"YY Fang","year":"2024","unstructured":"Fang YY, Liu J, Xin L, et al. Xinfeng capsule inhibits lncRNA NONHSAT227927.1\/TRAF2 to alleviate NF-\u03baB-p65-induced immuno-inflammation in ankylosing spondylitis. J Ethnopharmacol. 2024;323:117677.","journal-title":"J Ethnopharmacol"},{"key":"2034_CR87","volume":"12","author":"F Wang","year":"2021","unstructured":"Wang F, Chang J, Zhou GL, et al. The traditional chinese medicine compound Huangqin Qingre Chubi capsule inhibits the pathogenesis of rheumatoid arthritis through the CUL4B\/Wnt pathway. Front Pharmacol. 2021;12: 750233.","journal-title":"Front Pharmacol"},{"key":"2034_CR88","volume":"13","author":"DP Fan","year":"2022","unstructured":"Fan DP, Liu B, Gu XF, et al. Potential target analysis of triptolide based on transcriptome-wide m(6)A methylome in rheumatoid arthritis. Front Pharmacol. 2022;13: 843358.","journal-title":"Front Pharmacol"},{"key":"2034_CR89","volume":"95","author":"X Lin","year":"2022","unstructured":"Lin X, Tao C, Zhang R, et al. N6-methyladenosine modification of TGM2 mRNA contributes to the inhibitory activity of sarsasapogenin in rheumatoid arthritis fibroblast-like synoviocytes. Phytomedicine. 2022;95: 153871.","journal-title":"Phytomedicine"},{"key":"2034_CR90","doi-asserted-by":"crossref","first-page":"1041284","DOI":"10.3389\/fimmu.2022.1041284","volume":"13","author":"QS Geng","year":"2022","unstructured":"Geng QS, Cao XX, Fan DP, et al. Diagnostic gene signatures and aberrant pathway activation based on m6A methylation regulators in rheumatoid arthritis. Front Immunol. 2022;13:1041284.","journal-title":"Front Immunol"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-025-02034-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-025-02034-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-025-02034-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T16:55:42Z","timestamp":1767200142000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-025-02034-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,22]]},"references-count":90,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2034"],"URL":"https:\/\/doi.org\/10.1007\/s00011-025-02034-3","relation":{},"ISSN":["1023-3830","1420-908X"],"issn-type":[{"value":"1023-3830","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,22]]},"assertion":[{"value":"7 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"79"}}